NCT06427200

Efficacy and Safety of Lactoferrin in Heart Failure Patients

• Status: Not Yet Recruiting
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 114 (estimated)
• Sponsor: Cairo University · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

This study will be conducted to determine the efficacy and safety of lactoferrin versus oral iron versus lactoferrin plus oral iron as an add on therapy in reduced ejection fraction heart failure patients with iron deficiency. •Patients will be randomly distributed into the three groups * All patients will be subjected to baseline data assessment * Follow up after 12 weeks

Conditions

• Heart Failure With Reduced Ejection Fraction

Interventions

Type	Name	Description
DRUG	oral Iron	oral iron once daily during or after meals as add-on therapy for 12 weeks.
DRUG	Lactoferrin	lactoferrin twice daily before meals as add-on therapy for 12 weeks.
DRUG	lactoferrin and oral iron	lactoferrin twice daily before meals and oral iron once daily during or after meals as add-on therapy for 12 weeks.

Timeline

• Start date: 2024-07-01
• Primary completion: 2027-07-01
• Completion: 2027-07-01
• First posted: 2024-05-23
• Last updated: 2024-05-24